Integrated Quantitative Investments’s Anika Therapeutics ANIK Stock Holding History

Integrated Quantitative Investments’s Portfolio ANIK Stock Details ANIK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$279K	Buy	+19,079	New	+$283K	0.05%	335

Other funds holding ANIK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Capital Management Glen Allen, Virginia $666M AUM 17.17% 1-Year Est. Return

Integrated Quantitative Investments's ANIK Position: Q2 2026 in Review

Integrated Quantitative Investments opened a new position in Anika Therapeutics (ANIK) in Q2 2026: 19,079 shares worth $279K. The stake represents 0.05% of the portfolio and ranks #335 among its holdings.

133 funds tracked by Wall St. Rank hold ANIK as of Q2 2026.

Integrated Quantitative Investments held 19,079 shares of Anika Therapeutics worth $279K as of Q2 2026.
Anika Therapeutics was a new Integrated Quantitative Investments position in Q2 2026.
Anika Therapeutics made up 0.05% of Integrated Quantitative Investments's portfolio in Q2 2026, its #335 holding.
133 funds tracked by Wall St. Rank held Anika Therapeutics as of Q2 2026.

Based on Integrated Quantitative Investments's 13F filing for Q2 2026, filed 14 Aug 2026.